Notice to shareholders
2022-09-15
■ Our response to our shareholders’ inquiries about U.S. President Biden’s “Executive Order to launch a National Biotechnology and Biomanufacturing Initiative” are as follows:
■ After a thorough review of the Executive Order, we view it would have little, if any, impact on Celltrion Group.
■ Cell...